TNF and inflammatory bowel disease: Nonetheless, this study provides insights on the outcomes following first-line treatment with an anti-TNF therapy for IBD in China; the definition of suboptimal outcomes in this study was well established and aligned with a previous multinational chart review, allowing meaningful comparisons between countries [7, 9].